Habib Rahbar, M.D.

Associate Professor
Clinical Director of Breast Imaging, Seattle Cancer Care Alliance
Breast Imaging

Biography

Dr. Rahbar is an associate professor in the University of Washington (UW) Department of Radiology. A board certified radiologist, he works in the breast imaging section at the Seattle Cancer Care Alliance (SCCA) and serves as the Breast Imaging Clinical Director and Fellowship Director. Dr. Rahbar earned his bachelor’s degree from the University of Pennsylvania in Philadelpha and his M.D. from the University of Michigan in Ann Arbor. He completed his radiology residency training and breast imaging fellowship at the UW and stayed on as faculty upon graduation. His clinical practice at the SCCA includes digital mammography, digital breast tomosynthesis (or “3D mammography”), breast ultrasound, breast MRI, and image-guided procedures of the breast. Dr. Rahbar’s primary research interests include the identification of MRI features that can be used to improve management of ductal carcinoma in situ, the use of non-contrast MRI techniques to identify and characterize breast cancers, and the identification of MRI markers of risk of developing breast cancer.

Recent Publications (via Semantic Scholar)

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Shinn-Huey S Chou, J. Romanoff, C. Lehman, et al. - Published 2021 - RADIOLOGY

Intrinsic radiomics phenotypes of DCI from breast DCE-MRI: demonstrating feasibility in interim analysis of the ECOG-ACRIN E4112 trial
V. Belenky, Rhea D. Chitalia, Nickolas Lewis, et al. - Published 2021 - MEDICAL IMAGING

Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
Sarah H Chung, M. Wener, A. Bays, et al. - Published 2021 - ANNALS OF THE RHEUMATIC DISEASES

Predictors of surgery preference and quality of life in DCIS after breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (E4112).
S. Fazeli, B.S. Snyder, I. Gareen, et al. - Published 2021

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
Jennifer M Xiao, H. Rahbar, D. Hippe, et al. - Published 2021 - NPJ BREAST CANCER

Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
Sarah H Chung, M. Wener, A. Bays, et al. - Published 2021 - ANNALS OF THE RHEUMATIC DISEASES

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Shinn-Huey S Chou, J. Romanoff, C. Lehman, et al. - Published 2021 - RADIOLOGY

Editorial on “Diffusion‐Weighted Double‐Echo Steady‐State with a 3D Cones Trajectory for Non‐Contrast‐Enhanced Breast MRI”
H. Rahbar, S. Partridge - Published 2021 - JOURNAL OF MAGNETIC RESONANCE IMAGING : JMRI

Accuracy of Preoperative Breast MRI Versus Conventional Imaging in Measuring Pathologic Extent of Invasive Lobular Carcinoma.
Keegan K. Hovis, Janie M. Lee, D. Hippe, et al. - Published 2021 - JOURNAL OF BREAST IMAGING

Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702).
J. Whisenant, J. Romanoff, H. Rahbar, et al. - Published 2021 - JOURNAL OF BREAST IMAGING